Preferred Label : Erythrocyte Differentiation Pathway;
Alternative definition : BIOCARTA: Stem cells in the bone marrow produce a variety of hematopoietic cell types
from common progenitor cells under the influence of cytokines and growth factors.
CFU-GEMM cells are a key intermediate in the differentiation of granulocytes, erythrocytes,
monocytes and megakaryocytes. Erythropoietin (EPO) is a cytokine produced in the kidneys
that, along with other cytokines, induces red blood cell (erythrocyte) differentiation
in the bone marrow from CFU-GEMM cells. As the erythrocyte lineage progresses, cells
lose their nuclei, and move out of the bone marrow into circulation. The ability of
EPO to selectively induce red blood cell differentiation has allowed extensive therapeutic
use of the recombinant form of this cytokine to treat anemias. (This definition may
be outdated - see the DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_erythPathway;
Origin ID : C39073;
UMLS CUI : C1516959;
Semantic type(s)
has_gene_product_element
pathway_has_gene_element